Japan
· Delayed Price · Currency is JPY COSMOS Pharmaceutical Statistics
Total Valuation
COSMOS Pharmaceutical has a market cap or net worth of JPY 558.37 billion. The enterprise value is 533.77 billion.
| Market Cap | 558.37B |
| Enterprise Value | 533.77B |
Important Dates
The next estimated earnings date is Friday, January 10, 2025.
| Earnings Date | Jan 10, 2025 |
| Ex-Dividend Date | Nov 28, 2024 |
Share Statistics
COSMOS Pharmaceutical has 79.26 million shares outstanding. The number of shares has increased by 0.07% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 79.26M |
| Shares Change (YoY) | +0.07% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 38.76% |
| Owned by Institutions (%) | 25.13% |
| Float | 43.66M |
Valuation Ratios
The trailing PE ratio is 21.40 and the forward PE ratio is 21.26. COSMOS Pharmaceutical's PEG ratio is 3.03.
| PE Ratio | 21.40 |
| Forward PE | 21.26 |
| PS Ratio | 0.57 |
| PB Ratio | 2.35 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 3.03 |
Enterprise Valuation
| EV / Earnings | 20.46 |
| EV / Sales | 0.54 |
| EV / EBITDA | n/a |
| EV / EBIT | 15.87 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.72, with a Debt / Equity ratio of 0.11.
| Current Ratio | 0.72 |
| Quick Ratio | 0.24 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 258.75 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | 178.73M |
| Profits Per Employee | 4.73M |
| Employee Count | 5,512 |
| Asset Turnover | 2.14 |
| Inventory Turnover | 9.47 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.45% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -10.45% |
| 50-Day Moving Average | 7,348.62 |
| 200-Day Moving Average | 7,007.95 |
| Relative Strength Index (RSI) | 41.54 |
| Average Volume (20 Days) | 277,775 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, COSMOS Pharmaceutical had revenue of JPY 985.18 billion and earned 26.09 billion in profits. Earnings per share was 329.18.
| Revenue | 985.18B |
| Gross Profit | 195.86B |
| Operating Income | 33.64B |
| Pretax Income | 36.15B |
| Net Income | 26.09B |
| EBITDA | n/a |
| EBIT | 33.64B |
| Earnings Per Share (EPS) | 329.18 |
Balance Sheet
The company has 51.42 billion in cash and 26.82 billion in debt, giving a net cash position of 24.60 billion or 310.38 per share.
| Cash & Cash Equivalents | 51.42B |
| Total Debt | 26.82B |
| Net Cash | 24.60B |
| Net Cash Per Share | 310.38 |
| Equity (Book Value) | 237.20B |
| Book Value Per Share | 2,992.83 |
| Working Capital | -60.43B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 19.88%, with operating and profit margins of 3.41% and 2.65%.
| Gross Margin | 19.88% |
| Operating Margin | 3.41% |
| Pretax Margin | 3.67% |
| Profit Margin | 2.65% |
| EBITDA Margin | n/a |
| EBIT Margin | 3.41% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 65.00, which amounts to a dividend yield of 0.93%.
| Dividend Per Share | 65.00 |
| Dividend Yield | 0.93% |
| Dividend Growth (YoY) | 20.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.07% |
| Shareholder Yield | 0.85% |
| Earnings Yield | 4.67% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on August 29, 2024. It was a forward split with a ratio of 2.
| Last Split Date | Aug 29, 2024 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
COSMOS Pharmaceutical has an Altman Z-Score of 4.17.
| Altman Z-Score | 4.17 |
| Piotroski F-Score | n/a |